Novartis is delighted to be supporting Lung Foundation Australia to raise money for lung disease research. We are committed to improving access to healthcare and essential medicines and we continue to invest in future research.
Why Novartis thinks the cycle and the cause is important?
We know that more than 50% of all Australians rarely or never think about the health of their lungs. At Novartis we know how important the Corporate Cycle Challenge is in raising awareness of lung disease, encouraging Australians to take the health of their lungs seriously and giving lung disease the attention it deserves.
Are any of the Novartis’s team members affected by lung disease or know someone affected?
The Novartis team understands that Lung Disease does not discriminate – it equally impacts women, men, children, smokers and non-smokers. We will be signing up a team and encourage everyone in Brisbane to get involved and support this worthy and important cause.